Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients
Conditions:   Prediabetic State;   Impaired Fasting Glucose;   Impaired Glucose Tolerance Interventions:   Drug: Dapagliflozin 10mg Tab;   Behavioral: lifestyle interventions Sponsors:   Yangjin;   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials